Polyethylenimine Linear (PEI, MW 40,000): Benchmarks and Applications in DNA Transfection

Executive Summary: Polyethylenimine Linear (PEI, MW 40,000) is a cationic polymer that forms stable complexes with DNA, facilitating cellular uptake via endocytosis in serum-containing media [product]. PEI-mediated transfection achieves typical efficiencies between 60% and 80% in cell lines such as HEK-293, CHO-K1, and HeLa under optimized conditions [Roach 2024]. The reagent is suitable for scales from 96-well plates to 100 L bioreactors. Proper storage at -20°C ensures long-term stability, while 4°C is recommended for frequent use. PEI is integral for transient expression studies and recombinant protein production [internal contrast].

Biological Rationale

Polyethylenimine Linear (PEI, MW 40,000) is widely used for non-viral gene delivery in molecular and cell biology. The polymer's positive charge enables it to condense negatively charged nucleic acids, forming complexes that facilitate membrane association and endocytosis [Roach 2024]. This mechanism is compatible with serum-containing media, making PEI a practical choice for a broad range of cell lines and primary cells. PEI MW 40,000 is specifically optimized for high transfection efficiency and low cytotoxicity, supporting both small-scale and large-scale workflows [product page].

Mechanism of Action of Polyethylenimine Linear (PEI, MW 40,000)

PEI is a polycationic molecule that condenses DNA through electrostatic interaction, forming nanoscale complexes. These complexes exhibit a net positive charge, enhancing binding to the negatively charged cell membrane surface, particularly to proteoglycans and other anionic residues. The DNA-PEI complexes are internalized primarily by clathrin-mediated endocytosis and, less frequently, by caveolin-dependent pathways [internal link]. Once inside the cell, the proton-sponge effect of PEI facilitates endosomal escape, releasing the DNA into the cytoplasm for subsequent transcription. PEI MW 40,000’s linear structure provides a balance between efficient complexation and lower cytotoxicity compared to branched variants [internal link].

Evidence & Benchmarks

• PEI MW 40,000 achieves 60–80% transfection efficiency in HEK-293 and CHO-K1 cells using a 3:1 PEI:DNA (w/w) ratio in DMEM with 10% FBS; transfected at 37°C for 24–48 h (Roach 2024).
• DNA-PEI complexes remain stable in serum-containing media, allowing for direct use in standard culture conditions without the need for serum-free adaptation (Product Specifications).
• PEI-mediated transfection supports recombinant protein yields of up to 200 mg/L in large-scale (10–100 L) bioreactor cultures of HEK293T cells (Mechanistic Review).
• Cytotoxicity screens in HepG2 and HeLa cells (using MTT assay) show >85% viability at ≤3 μg/mL PEI after 48 h incubation (Roach 2024, Table 2).
• PEI MW 40,000 is compatible with a range of DNA payloads, including plasmids up to 15 kb, and is used for both transient and stable transfection protocols (Application Note).

Applications, Limits & Misconceptions

• PEI MW 40,000 is applicable for transient transfection, stable line generation, and large-scale protein production in mammalian cells.
• It is validated for commonly used lines, including HEK-293, HEK293T, CHO-K1, HeLa, and HepG2.
• The reagent is effective in serum-containing and serum-free conditions, supporting parallel workflows.
• It can be used in 96-well to 100 L bioreactor formats, providing scalability for research and preclinical manufacturing.

Common Pitfalls or Misconceptions

• PEI is not suitable for in vivo gene delivery due to toxicity and immune response risks.
• Excess PEI (>5 μg/mL) increases cytotoxicity and reduces transfection efficiency.
• Serum starvation is not required; PEI complexes are stable in 10% FBS.
• Improper PEI:DNA ratio (<2:1) can result in poor complex formation and low uptake.
• Repeated freeze-thaw cycles degrade PEI and compromise performance; aliquot and store at -20°C for long-term, 4°C for frequent use.

This article extends the analysis in 'Polyethylenimine Linear: Innovations' by providing quantitative benchmarks and clarifying the serum compatibility of PEI MW 40,000 for routine workflows. For a broader strategic view, see 'From Mechanism to Medicine: Polyethylenimine Linear', which contextualizes PEI's role in translational research beyond in vitro applications.

Workflow Integration & Parameters

• Preparation: Dilute PEI MW 40,000 to 2.5 mg/mL in sterile water or PBS. Filter-sterilize through 0.22 μm if needed.
• Complexation: Mix DNA and PEI at a 1:3 (w/w) ratio; incubate for 15–20 min at room temperature to form complexes.
• Cell culture: Apply complexes to adherent or suspension cells in complete media (e.g., DMEM + 10% FBS).
• Incubation: Culture at 37°C, 5% CO₂ for 24–48 h. Assess transfection by fluorescence microscopy or qPCR.
• Scale-up: For large-scale transfection, maintain the same PEI:DNA ratio and adjust volumes accordingly. Use bioreactor-compatible protocols for 10–100 L cultures.
• Storage: Aliquot and store PEI at -20°C for long-term. For frequent use, 4°C avoids repeated freeze-thaw cycles.

Conclusion & Outlook

Polyethylenimine Linear (PEI, MW 40,000) provides a robust, scalable platform for DNA transfection in molecular biology. Its proven efficiency, serum compatibility, and cytocompatibility make it a standard for transient gene expression and recombinant protein production [K1029 kit]. Ongoing research in nanoparticle and gene delivery optimization may further enhance PEI’s value in translational and therapeutic settings [Roach 2024].